Cytochrome P450TB (CYP2C): A major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liver

This publication has 15 references indexed in Scilit:

• In vitro oxidation of oxicam NSAIDs by a human liver cytochrome P450
  Published by Elsevier ,2002
• Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions
  Chemical Research in Toxicology, 1992
• Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily
  Biochemistry, 1991
• Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9
  Biochemical and Biophysical Research Communications, 1991
• The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended Nomenclature
  DNA and Cell Biology, 1991
• Metabolic enantiomeric interactions: The inhibition of human (S)-warfarin-7-hydroxylase by (R)-warfarin
  Chirality, 1991
• Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae
  Biochemistry, 1989
• Tolbutamide hydroxylation by human liver microsomes
  Biochemical Pharmacology, 1988
• Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation
  Biochemical Pharmacology, 1987
• Biotransformation of Diclofenac Sodium (Voltaren®) in Animals and in Man.: II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile
  Xenobiotica, 1979